The Business Research Company's latest study on Anti-Viral Drug Therapy Global Market Report 2020-30: Covid 19 Implications And Growth

LONDON, GREATER LONDON, UK, April 21, 2020 /EINPresswire.com/ -- The global anti-viral drug therapy market is expected to grow from $52.2 billion in 2019 to about $59.9 billion in 2020 as there is a surge in demand for antiretroviral drugs used in the treatment of COVID-19 patients. The market is expected to stabilize and reach $62.6 billion at a growth rate of about 4.6% through 2023. Increasing public-private funding for life science research globally is expected to drive the growth of anti-viral drug therapy market. However, the emergence of alternative therapies such as naturopathy and homeopathy for the treatment of viral infections is negatively affecting the market.

The anti-viral drug therapy market consists of sales of anti-viral drugs used for the treatment of viral infections such as human immunodeficiency virus (HIV), hepatitis, influenza and novel coronavirus. Antiviral drugs do not kill their target pathogen, instead they inhibit the development of those viruses. The anti-viral drugs establishments are primarily engaged in the manufacturing of DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, neuraminidase inhibitors, and others.

Request For A Free Sample For The Global Anti-Viral Drug Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2831&type=smp

The global anti-viral drug therapy market is further segmented based on type and geography.
By Drug Class: DNA Polymerase Inhibitors; Reverse Transcriptase Inhibitors; Protease Inhibitors; Neuraminidase Inhibitors; Others

By Application: HIV; Hepatitis; Herpes; Influenza; Others

By Geography - The global anti-viral drug therapy market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, the North American anti-viral drug therapy market accounts for the largest share in the global anti-viral drug therapy market.

Read More On The Report For The Global Anti-Viral Drug Therapy Market At:
https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market-global-report-2020-2030-covid-19-implications-and-growth

Trends In The Anti-Viral Drug Therapy Market

Companies in the anti-viral drug therapy market are continuously innovating through technological advancements to develop drugs for treating different viral infections. Biopharmaceutical companies are developing vaccines for the treatment of novel coronavirus.

Anti-Viral Drug Therapy Global Market Report 2020 is one of a series of new reports from The Business Research Company that provides anti-viral drug therapy market overviews, analyzes and forecasts anti-viral drug therapy market size and growth for the global anti-viral drug therapy market, anti-viral drug therapy market share, anti-viral drug therapy market players, anti-viral drug therapy market size, anti-viral drug therapy market segments and geographies, anti-viral drug therapy market trends, anti-viral drug therapy market drivers and anti-viral drug therapy market restraints, anti-viral drug therapy market’s leading competitors’ revenues, profiles and market shares. The anti-viral drug therapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More
Read Anti-Viral Drug Therapy Global Market Report 2020 from The Business Research Company for information on the following:

Markets Covered: Global Anti-Viral Drug Therapy Market

Data Segmentations: Anti-Viral Drug Therapy Market Size, Global And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Anti-Viral Drug Therapy Market Organizations Covered: AbbVie Inc., Bristol-Myers-Squibb, Cipla, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd, AstraZeneca plc.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa
Time Series: Five years historic (2015-19) and forecast (2019-23)

Other Information And Analyses: PESTEL analysis, anti-viral drug therapy market customer information, anti-viral drug therapy market product/service analysis – product examples, anti-viral drug therapy market trends and opportunities, drivers and restraints, key mergers and acquisitions, key metrics covered: number of enterprises, number of employees, global anti-viral drug therapy market in 2020 - countries offering most new opportunities

Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.

Strategies For Participants In The Anti-Viral Drug Therapy Industry: The report explains a number of strategies for companies in the anti-viral drug therapy market, based on industry trends and company analysis.

Opportunities For Companies In The Anti-Viral Drug Therapy Sector: The report reveals where the global anti-viral drug therapy industry will put on most $ sales up to 2023.

Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets. Here is a list of reports from The Business Research Company similar to the Anti-Viral Drug Therapy Global Market Report 2020:

HIV Drugs Global Market Report 2020-30: COVID-19 Implications and Growth
Interferons Global Market Report 2020-30: COVID-19 Implications and Growth
Molecular Diagnostics Market Global Report 2020: COVID-19 Implications And Growth

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn